Key points are not available for this paper at this time.
Objectives: Chronic migraineurs having failed more than 3 preventive drugs were treated with Erenumab alone or as an add on therapy, we assessed the frequency of monthly migraine days, the value of an add on therapy, and all adverse events.
Guy Boudreau (Tue,) studied this question.